If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

  • This share is currently suspended. It was suspended at a price of 650.00
  • There is currently no data for HAT

Holding(s) in Company

22 Mar 2007 14:57

H&T Group PLC22 March 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: H&T Group plc - GB00B12RQD06 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: ( ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( X ) Other (please specify) : ( ) ................. 3. Full name of person(s) subject to the notification obligation: UBS Global Asset Management - Traditional 4. Full name of shareholder(s) (if different from 3.) : UBS Global Asset Management (UK) Limited UBS Global Asset Management Life Limited 5. Date of the transaction (and date on which the threshold is crossed orreached if different): 16 March 2007 (See 13. Additional information) 6. Date on which issuer notified: 20 March 2007 7. Threshold(s) that is/are crossed or reached: 9.20% 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering transactionusing the ISIN CODE Number of shares Number of voting Rights GB00B12RQD06 2,310,707 2,310,707 Resulting situation after the triggering transaction Class/type of shares if Number of shares Number of voting rights % of voting rightspossible using the ISIN CODE Direct Direct Indirect Direct Indirect GB00B12RQD06 2,896,976 2,310,707 586,269 7.33% 1.86% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rightsfinancial Period/ Date that may be acquired if theinstrument instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 2,896,976 9.20% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable : UBS Global Asset Management (UK) Limited - 586,269- 1.86% UBS Global Asset Management Life Limited - 2,310,707 - 7.33% Proxy Voting: 10. Name of the proxy holder: UBS Global Asset Management on behalf of a number of asset management clients 11. Number of voting rights proxy holder will cease to hold: ................. 12. Date on which proxy holder will cease to hold voting rights: ................. 13. Additional information: This disclosure has been made to fulfil the below FSA requirement: The Transparency Directive states that where a major shareholder has not beenrequired (because of an acquisition or disposal of voting rights or due to achange in the total of voting rights in issue) to make an announcement to theissuer prior to the 20th March 2007, then we must do so by that date in anyevent. Please note that UBS are no longer required to include prime brokerage holdingsin the disclosures under DTR5. 14. Contact name: Angela Huff, Associate Director, UBS AG 15. Contact telephone number: 0207 568 4981 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Sep 20224:43 pmRNSProposed Capital Raise of up to £16.9m
9th Sep 20227:00 amRNSAppointment of Non-Executive Director
18th Aug 202210:33 amRNSHolding(s) in Company
17th Aug 20225:20 pmRNSStandard form for notification of major holdings
9th Aug 20227:00 amRNSInterim Results
8th Jul 20229:08 amRNSHolding(s) in Company
6th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:01 amRNSAcquisition of Swiss Time Services Limited
4th Jul 20227:00 amRNSTrading Update and Notice of Results
29th Jun 20226:18 pmRNSHolding(s) in Company
30th May 20227:00 amRNSPerformance Share Plan ("PSP") 2022
13th May 20227:00 amRNSResult of AGM
12th May 20227:00 amRNSTrading Update
3rd May 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20223:22 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSAppointment of non-executive director
4th Apr 20227:00 amRNSUpdate on regulatory review into HCST lending
25th Mar 20221:49 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Jan 20227:00 amRNSTrading Update and Notice of Results
17th Jan 20227:00 amRNSChange of Nominated Adviser and Broker
20th Dec 20217:00 amRNSAnnouncement – Rule 17 Schedule 2(g) Updated
24th Nov 20219:52 amRNSDirector appointed
19th Nov 202112:08 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotification of major holdings
1st Nov 202110:22 amRNSH&T CFO appointment update
5th Oct 20212:30 pmRNSNotification of major holdings
10th Aug 20217:00 amRNSCorrection to Ex-Dividend and Record Date
9th Aug 20217:00 amRNSChief Finance Officer Appointment
9th Aug 20217:00 amRNSUnaudited Interim Results
21st Jul 20217:00 amRNSNotice of Interim Results
5th Jul 202111:56 amRNSPDMR Dealing
20th May 20213:00 pmRNSResult of Annual General Meeting
30th Apr 20217:00 amRNSBoard Changes - Chief Financial Officer
26th Apr 20217:00 amRNSPosting of Report & Accounts and Notice of AGM
23rd Mar 20217:00 amRNSPreliminary results for the year ended 31 Dec 2020
22nd Feb 20217:00 amRNSNotification of major holdings
25th Jan 20217:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
20th Nov 20207:00 amRNSDirector Dealings
9th Nov 20205:22 pmRNSChange of Auditor
5th Nov 202011:00 amRNSBusiness update
2nd Nov 20207:00 amRNSChange of Auditor
29th Oct 20207:00 amRNSH&T CEO appointment
26th Oct 20207:00 amRNSDirectorate Change
13th Oct 20204:35 pmRNSPrice Monitoring Extension
25th Sep 20207:00 amRNSDirector Dealings
25th Aug 20204:35 pmRNSPrice Monitoring Extension
14th Aug 20208:37 amRNSTR-1: Notification of major holdings
13th Aug 20201:50 pmRNSAIM Rule 17 disclosure
11th Aug 20202:50 pmRNSInterim Results – Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.